BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35727459)

  • 1. Percutaneous cryoablation for clinical T3a renal cell carcinoma (< 7 cm) with segmental vein involvement or perinephric fat invasion based on preoperative evaluation of high-resolution multidetector computed tomography scan.
    Uka M; Iguchi T; Okawa N; Matsui Y; Tomita K; Umakoshi N; Munetomo K; Gobara H; Araki M; Hiraki T
    Jpn J Radiol; 2022 Nov; 40(11):1201-1209. PubMed ID: 35727459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cryoablation combined with prior transcatheter arterial embolization in non-dialysis patients with stage 4 or 5 chronic kidney disease: a retrospective study.
    Umakoshi N; Iguchi T; Matsui Y; Tomita K; Uka M; Kawabata T; Munetomo K; Nagata S; Gobara H; Araki M; Hiraki T
    Jpn J Radiol; 2023 Sep; 41(9):1007-1014. PubMed ID: 37002430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT evaluation of patent artery after percutaneous cryoablation of renal cell carcinoma.
    Kajita S; Iguchi T; Hiraki T; Matsui Y; Tomita K; Uka M; Tanaka T; Araki M; Gobara H; Kanazawa S
    Diagn Interv Imaging; 2021 Dec; 102(12):753-758. PubMed ID: 34144934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Oncologic Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma Recurrences in the Ipsilateral Kidney Following Partial Nephrectomy.
    Rossi J; Cazzato RL; de Marini P; Auloge P; Autrusseau PA; Dalili D; Tricard T; Poussot B; Garnon J; Lang H; Gangi A
    Cardiovasc Intervent Radiol; 2022 May; 45(5):656-664. PubMed ID: 35274173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous cryoablation combined with prior transcatheter arterial embolization for renal cell carcinomas of 3 cm or larger: a prospective study.
    Gobara H; Matsui Y; Uka M; Tomita K; Umakoshi N; Araki M; Sakurai J; Iguchi T; Hiraki T
    Int J Clin Oncol; 2022 Oct; 27(10):1589-1595. PubMed ID: 35945389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
    Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous CT- and MRI-guided Cryoablation of cT1 Renal Cell Carcinoma: Intermediate- to Long-term Outcomes in 307 Patients.
    Bhagavatula SK; Tuncali K; Shyn PB; Levesque VM; Chang SL; Silverman SG
    Radiology; 2020 Sep; 296(3):687-695. PubMed ID: 32633677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Cryoablation of Renal Cell Carcinoma with Sinus Vein Involvement Based on Preprocedural Imaging.
    Atwell TD; Kurup AN; Boorjian SA; Schmitz JJ; Thompson RH; Leibovich BC; Schmit GD
    J Vasc Interv Radiol; 2017 Dec; 28(12):1651-1657. PubMed ID: 29042169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced Computed Tomography-Guided Percutaneous Cryoablation of Renal Cell Carcinoma in a Renal Allograft: First Case in Asia.
    Tsuboi I; Araki M; Fujiwara H; Iguchi T; Hiraki T; Arichi N; Kawamura K; Maruyama Y; Mitsui Y; Sadahira T; Kubota R; Nishimura S; Sako T; Takamoto A; Wada K; Kobayashi Y; Watanabe T; Yanai H; Kitagawa M; Tanabe K; Sugiyama H; Wada J; Shiina H; Kanazawa S; Nasu Y
    Acta Med Okayama; 2019 Jun; 73(3):269-272. PubMed ID: 31235976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
    Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
    J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation.
    Okhunov Z; Chamberlin J; Moreira DM; George A; Babaian K; Shah P; Youssef R; Kaler KS; Lobko II; Kavoussi L; Landman J
    J Endourol; 2016 Jun; 30(6):632-7. PubMed ID: 27009377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
    Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
    Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
    Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
    J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryoablation of renal cell carcinoma for patients with stage 4 or 5 non-dialysis chronic kidney disease.
    Gobara H; Nakatsuka A; Shimizu K; Yamanaka T; Matsui Y; Iguchi T; Hiraki T; Yamakado K
    Jpn J Radiol; 2019 Jun; 37(6):481-486. PubMed ID: 30941617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative lipiodol marking and its role on survival and complication rates of CT-guided cryoablation for small renal masses.
    Hongo F; Yamada Y; Ueda T; Nakmura T; Naya Y; Kamoi K; Okihara K; Ichijo Y; Miki T; Yamada K; Ukimura O
    BMC Urol; 2017 Jan; 17(1):10. PubMed ID: 28100214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience.
    Atwell TD; Farrell MA; Callstrom MR; Charboneau JW; Leibovich BC; Patterson DE; Chow GK; Blute ML
    Radiology; 2007 Apr; 243(1):276-83. PubMed ID: 17329689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic outcomes and safety of percutaneous cryoablation for biopsy-proven renal cell carcinoma up to 4 cm in diameter: a prospective observational study.
    Gobara H; Hiraki T; Iguchi T; Matsui Y; Sakurai J; Uka M; Tomita K; Komaki T; Kobayasi Y; Araki M; Watanabe T; Kanazawa S
    Int J Clin Oncol; 2021 Mar; 26(3):562-568. PubMed ID: 33174078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift?
    Aoun HD; Littrup PJ; Jaber M; Memon F; Adam B; Krycia M; Prus M; Heath E; Pontes E
    J Vasc Interv Radiol; 2017 Oct; 28(10):1363-1370. PubMed ID: 28844831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Function After CT-Guided Cryoablation of Small Renal Tumours in Patients with Solitary Kidney: An Analysis of European Multinational Prospective EuRECA Registry.
    Pietersen PI; Stougaard S; Keeley FX; Lagerveld B; Breen D; King A; Nielsen TK; van Strijen M; Garnon J; Alcorn D; de Kerviler E; Zondervan P; Wah TM; Junker T; Graumann O
    Cardiovasc Intervent Radiol; 2024 May; 47(5):583-589. PubMed ID: 38273129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.